Filing Flows › Comparisons › HCWB vs COCP
HCW Biologics vs Cocrystal Pharma: HCWB and COCP compared
HCW Biologics is the larger company: $136K of revenue in its latest quarter (Q2 2026) against $105K for Cocrystal Pharma (Q2 2026).
Where the money goes: HCWB and COCP
HCW Biologics (HCWB) · Q2 2026
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Cocrystal Pharma (COCP) · Q2 2026
Cocrystal Pharma, Q2 2026: revenue $105K, net loss $3.2M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| HCW Biologics (HCWB) | Cocrystal Pharma (COCP) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $136K | $105K |
| Revenue growth, Y/Y | 21× | — |
| Operating margin | n/m | n/m |
| Net earnings | −$5.2M | −$3.2M |
| Operating cash flow | −$4.0M | −$2.5M |
Questions
Which is bigger, HCW Biologics or Cocrystal Pharma?
HCW Biologics is the larger company: $136K of revenue in its latest quarter (Q2 2026) against $105K for Cocrystal Pharma (Q2 2026).
More: HCW Biologics earnings · how HCW Biologics makes money · Cocrystal Pharma earnings · how Cocrystal Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.